Dual therapeutic approach to modulate Glycogen Synthase kinase -3 beta (GSK-3Β) and inhibitor of nuclear factor kappa kinase-beta (IKK-ß) receptors by in silico designing of inhibitors.
J Mol Graph Model
; 115: 108225, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35636338
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Enzyme Inhibitors
/
I-kappa B Kinase
Type of study:
Prognostic_studies
Language:
En
Journal:
J Mol Graph Model
Journal subject:
BIOLOGIA MOLECULAR
Year:
2022
Document type:
Article
Affiliation country:
India